Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia

    Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia supports healthcare teams' local quality improvement projects to improve diagnosis, treatment, and adult care.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Advancing Multidisciplinary Care in Hemophilia

    Advancing Multidisciplinary Care in Hemophilia supports healthcare teams in mainland China with quality improvement projects to strengthen coordinated care and improve outcomes for people with hemophilia.

    PfizerDue Jan 28, 2027$20,000

    Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings

    Funds collaborative early-stage research and tool development for new small molecule antibiotics targeting Klebsiella spp. and other Gram-negative Enterobacteriaceae.

    Gates FoundationRolling submissions$5,000,000

    Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections

    Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections funds independent researchers studying treatment outcomes to improve patient care.

    PfizerDue Dec 21, 2026$41,250

    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)

    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI) supports researchers studying diagnostic-guided treatment of resistant infections to assess timeliness and effectiveness.

    PfizerDue Nov 25, 2026$50,000

    Pfizer Research and Quality Improvement Grant Request for Proposals

    Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.

    PfizerDue Nov 15, 2026· 12d$50,000